Call for Papers: Vaccine Adjuvant Process, Formulation, and Characterization
Molecular Pharmaceutics · 10.11.2026
DOI: 10.1021/acs.molpharmaceut.6c01492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 10.11.2026. Verfasst von Joe Vanderburgh und 2 weiteren Autor:innen.
Abstract (Originalsprache)
M olecular Pharmaceutics is excited to announce a Call for Papers for a Special Issue titled "Vaccine Adjuvant Process, Formulation, and Characterization."This Special Issue is dedicated to highlighting cutting-edge pharmaceutical science that translates complex immunological concepts into stable, manufacturable, and safe vaccine products.Vaccines remain one of the most profound achievements in global public health.However, as the field shifts toward highly purified subunit, recombinant, and synthetic antigens to improve safety profiles, these antigens often suffer from reduced immunogenicity.This necessitates the use of advanced adjuvant systems.The landscape of adjuvants has rapidly expanded beyond traditional aluminum salts to include complex, multiphase systems such as lipid-based nanoparticles, liposomes, and emulsions incorporating specialized immunostimulants of various modalities.While these complex adjuvant systems represent the frontier of preventative and therapeutic vaccines, they introduce profound physicochemical and engineering challenges.Navigating component interactions, maintaining critical quality attributes during manufacturing, and ensuring long-term stability require rigorous innovation.This Special Issue seeks to capture advances across the entire continuum of adjuvant developmentfrom early-stage adjuvant formulation design optimization to continuous manufacturing technologies and occupational safety.We invite original research articles, communications, perspectives, and comprehensive reviews (by invitation or proposal only) that fit within the scope of Molecular Pharmaceutics and highlight exciting developments in adjuvant science.Submissions are encouraged in the following thematic areas, but not limited to:Formulation Science & Design
Zitieren
APA
Vanderburgh, J., Blanco, M., & Esser-Kahn, A. (2026). Call for Papers: Vaccine Adjuvant Process, Formulation, and Characterization. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c01492
Vancouver
Vanderburgh J, Blanco M, Esser-Kahn A. Call for Papers: Vaccine Adjuvant Process, Formulation, and Characterization. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.6c01492
BibTeX
@article{Vanderburgh2026,
author = {Vanderburgh, Joe and Blanco, Marco and Esser-Kahn, Aaron},
title = {Call for Papers: Vaccine Adjuvant Process, Formulation, and Characterization},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.6c01492}
}
EUVIMED